Newbridge Financial Services Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Newbridge Financial Services Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4K	Hold	64	–	–	﹤0.01%	767
2026 Q1	$12.1K	Hold	64	–	–	﹤0.01%	759
2025 Q4	$10.9K	Sell	64 -43	-40%	-$6.59K	﹤0.01%	767
2025 Q3	$14.1K	Sell	107 -185	-63%	-$22.2K	﹤0.01%	826
2025 Q2	$31K	Hold	292	–	–	0.01%	608
2025 Q1	$36.3K	Sell	292 -176	-38%	-$23K	0.01%	435
2024 Q4	$57.6K	Hold	468	–	–	0.01%	373
2024 Q3	$52.1K	Hold	468	–	–	0.02%	249
2024 Q2	$50K	Hold	468	–	–	0.02%	371
2024 Q1	$56.4K	Hold	468	–	–	0.02%	372
2023 Q4	$57.6K	Buy	468 +336	+255%	+$41.9K	0.03%	364
2023 Q3	$17.1K	Hold	132	–	–	0.01%	680
2023 Q2	$16.4K	Hold	132	–	–	0.01%	751
2023 Q1	$19.3K	Hold	132	–	–	0.01%	737
2022 Q4	$21K	Hold	132	–	–	0.01%	707
2022 Q3	$18K	Hold	132	–	–	0.01%	726
2022 Q2	$21K	Hold	132	–	–	0.01%	643
2022 Q1	$21K	Hold	132	–	–	0.01%	718
2021 Q4	$17K	Sell	132 -6	-4%	-$789	0.01%	778
2021 Q3	$18K	Buy	138 +6	+5%	+$907	0.01%	693
2021 Q2	$23K	Buy	132 +116	+725%	+$20.1K	0.01%	735
2021 Q1	$3K	Buy	+16	New	+$2.63K	﹤0.01%	1123

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Newbridge Financial Services Group's JAZZ Position: Q2 2026 in Review

Newbridge Financial Services Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 64 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Newbridge Financial Services Group first reported a position in JAZZ in Q1 2021 and has held it in 22 quarters since. The position peaked at $57.6K in Q4 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Newbridge Financial Services Group held 64 shares of Jazz Pharmaceuticals worth $15.4K as of Q2 2026.
Newbridge Financial Services Group left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #767 holding.
Newbridge Financial Services Group first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
Newbridge Financial Services Group's Jazz Pharmaceuticals position peaked at $57.6K in Q4 2024.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.